22-hydroxycholesterol has been researched along with farnesyl pyrophosphate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cress, AB; Duleba, AJ; Moeller, BC; Ortega, I; Sokalska, A; Stanley, SD; Villanueva, JA; Wong, DH | 1 |
1 other study(ies) available for 22-hydroxycholesterol and farnesyl pyrophosphate
Article | Year |
---|---|
Simvastatin reduces steroidogenesis by inhibiting Cyp17a1 gene expression in rat ovarian theca-interstitial cells.
Topics: Alkyl and Aryl Transferases; Animals; Cells, Cultured; Farnesyltranstransferase; Female; Gene Expression Regulation, Enzymologic; Hydroxycholesterols; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ovary; Polyisoprenyl Phosphates; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; RNA, Messenger; Sesquiterpenes; Simvastatin; Steroid 17-alpha-Hydroxylase; Substrate Specificity | 2012 |